Your browser is no longer supported. Please, upgrade your browser.
GWPH GW Pharmaceuticals plc daily Stock Chart
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-10.46 Insider Own0.62% Shs Outstand30.05M Perf Week0.63%
Market Cap5.12B Forward P/E- EPS next Y-3.63 Insider Trans-91.23% Shs Float29.58M Perf Month13.47%
Income-301.90M PEG- EPS next Q-1.38 Inst Own81.50% Short Float10.59% Perf Quarter43.01%
Sales11.80M P/S433.94 EPS this Y77.60% Inst Trans13.13% Short Ratio5.99 Perf Half Y20.90%
Book/sh22.07 P/B7.72 EPS next Y3.30% ROA- Target Price188.17 Perf Year45.47%
Cash/sh19.68 P/C8.66 EPS next 5Y- ROE- 52W Range90.14 - 182.23 Perf YTD74.97%
Dividend- P/FCF- EPS past 5Y-23.00% ROI-10.80% 52W High-6.49% Beta2.82
Dividend %- Quick Ratio9.30 Sales past 5Y-26.00% Gross Margin43.60% 52W Low89.04% ATR6.32
Employees791 Current Ratio9.80 Sales Q/Q17.50% Oper. Margin- RSI (14)61.31 Volatility3.12% 3.98%
OptionableYes Debt/Eq0.00 EPS Q/Q-30.40% Profit Margin- Rel Volume0.63 Prev Close168.11
ShortableYes LT Debt/Eq0.02 EarningsFeb 26 AMC Payout- Avg Volume523.21K Price170.40
Recom1.80 SMA203.43% SMA5014.77% SMA20020.59% Volume328,932 Change1.36%
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Sep-26-16Reiterated Cantor Fitzgerald Buy $165 → $182
Aug-26-16Upgrade Numis Sell → Hold
Aug-09-16Reiterated Cantor Fitzgerald Buy $181 → $165
Mar-20-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
01:45PM  These Four Marijuana Stocks Are Bringing The Heat On Wednesday ACCESSWIRE
Mar-18-19 03:54PM  Buy Marijuana Stocks Now? You'd Have to Be Stoned. Kiplinger
12:56PM  2 Hemp Stocks for Investors Looking for Something Different
08:21AM  2 Brand-Name Pot Stocks That Will Lose Money in 2020 Motley Fool
07:46AM  GW Pharma announces sale of priority review voucher for $105 million MarketWatch
07:30AM  GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M GlobeNewswire
Mar-16-19 12:00PM  Better Marijuana Stock: Aurora Cannabis vs. GW Pharmaceuticals Motley Fool
Mar-15-19 09:13AM  Moving Average Crossover Alert: GW Pharmaceuticals Zacks
Mar-14-19 08:55AM  Three of the Influential Health and Wellness Cannabis Companies ACCESSWIRE
Mar-12-19 10:00AM  Top Cannabis Plays-THC Therapeutics, Inc ACCESSWIRE
Mar-11-19 09:30AM  Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year? Zacks
Mar-10-19 11:41AM  The War on Tobacco, E-Cigs, and CBD May Be Coming to an End Motley Fool
Mar-08-19 06:35AM  Edited Transcript of GWPH.O earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-06-19 12:22PM  The Marijuana Industry: Everything You Need to Know Motley Fool
11:30AM  Non-Opioid Treatment Cos. for Investors in Wake of Purdue Pharma News ACCESSWIRE
Mar-05-19 02:13PM  Piper Jaffray: Tilray, GW Pharma Are Early Leaders In Medical Cannabis Benzinga
10:10AM  Top Marijuana Stocks on the NASDAQ Investopedia
09:15AM  S&P Below 2800 Again after Monday Selloff Zacks
07:21AM  3 Marijuana Stocks to Avoid Like the Plague in March Motley Fool
Mar-04-19 11:12AM  How the cannabis industry could be worth a trillion dollars in a decade Investopedia
10:10AM  GW, Hasbro, Salesforce, American Express and Intuit highlighted as Zacks Bull and Bear of the Day Zacks
07:54AM  Breakeven On The Horizon For GW Pharmaceuticals plc (NASDAQ:GWPH) Simply Wall St.
06:00AM  5 Best Marijuana Stocks in February -- Are They Buys Now? Motley Fool
05:01AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Mar-03-19 11:00AM  Why Marijuana Stock GW Pharmaceuticals Jumped 20.5% in February Motley Fool
Mar-01-19 04:32PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
Feb-28-19 07:01PM  Jim Cramer: My Best Stock Picks for Cannabis and China
10:21AM  New Cannabis Products Which Could Disrupt the Industry in 2019 Investopedia
10:16AM  GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock
06:54AM  Cannabis stocks tumble as GW Pharma rallies after strong Epidiolex launch MarketWatch
Feb-27-19 10:15PM  Why GW Pharmaceuticals Sizzled in Q4 -- and Why Next Quarter Will Probably Be Even Better Motley Fool +13.80%
08:49PM  What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)
06:50PM  GW Pharmaceuticals CEO: How we separate ourselves from medical marijuana companies CNBC Videos
04:28PM  Why GW Pharmaceuticals, MercadoLibre, and IMAX Jumped Today Motley Fool
04:21PM  This Cannabis Biotech Stock Popped Higher On Its CBD Oil Drug Investor's Business Daily
04:14PM  Cantor Reiterates Bullish View On GW Pharmaceuticals Following Earnings Benzinga
01:00PM  Watch These Four Marijuana Stocks Test Their Limits on Thursday ACCESSWIRE
10:57AM  GW Pharma Breaks Out After Strong Earnings Investopedia
10:55AM  Why GW Pharmaceuticals Is Crushing It Today Motley Fool
09:29AM  Is Marijuana Stock GW Pharmaceuticals a Buy Following Its Quarterly Results? Motley Fool
09:02AM  GW Pharmaceuticals stock soars after earnings report prompts upbeat analyst calls MarketWatch
08:21AM  3 Arguments For and Against Buying GW Pharmaceuticals Motley Fool
Feb-26-19 08:43PM  GW Pharmaceuticals Shs Sponsored American Deposit Share Repr 12 Shs (GWPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:43PM  GW Pharmaceuticals Earnings: GWPH Stock Soars as Q1 Revenue Triples InvestorPlace
04:40PM  GW Pharmaceuticals Sees 68% Q1 Revenue Growth Following Epidiolex Launch Benzinga
04:12PM  GW Pharmaceuticals stock rises after earnings beat MarketWatch
04:01PM  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 GlobeNewswire
01:33PM  GW Pharma (GWPH) Stock Could Surge on Earnings Today SmarterAnalyst
11:08AM  GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-24-19 09:00AM  Is GW Pharmaceuticals a Buy? Motley Fool
Feb-23-19 09:06AM  Trump Continues to Flip-Flop on Medical Marijuana Motley Fool
Feb-22-19 04:48PM  Thailand Legalizes Medical Weed: What's Next? Benzinga +5.31%
04:38PM  Marijuana Stocks and ETFs: Risks and Rewards Zacks
12:30PM  Four Marijuana Stocks Leading Friday's Bull Charge ACCESSWIRE
Feb-21-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know Zacks
04:12PM  What Investors Need to Know About Investing in Marijuana Stocks Zacks
02:31PM  ETFs and Stocks to Tap the Marijuana Boom Zacks
Feb-20-19 03:01PM  New York City Bans CBD Edibles: What Now? Benzinga
10:27AM  The Zacks Analyst Blog Highlights: GW, Innovative, KushCo, Canopy and Constellation Zacks
Feb-19-19 03:59PM  4 Marijuana Stocks to Watch in 2019 Zacks
02:21PM  Top Stock Picks for the Week of Feb 19, 2019 Zacks
Feb-14-19 02:15PM  Why Marijuana ETFs are on a High in 2019 Zacks
08:21AM  3 Very Popular Marijuana Stocks You Couldn't Pay Me to Buy Motley Fool
Feb-13-19 05:55PM  4 Best Marijuana Stocks to Play the Green Rush Zacks
02:30PM  4 Marijuana Stocks Bubbling with Excitement on Wednesday (2/13/19) ACCESSWIRE
01:47PM  Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks? InvestorPlace
09:00AM  Biotech and Cannabis Stocks That Are Emerging ACCESSWIRE
04:06AM  The Future of the Marijuana Industry in America Investopedia
Feb-11-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
09:41AM  Why Marijuana Stock GW Pharmaceuticals Soared 46.6% in January Motley Fool
Feb-10-19 11:41AM  3 Legal Marijuana States Are Banning CBD Edibles. Here's Why. Motley Fool
Feb-08-19 06:28PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga +5.50%
02:35PM  4 Marijuana Stocks Looking To Pick Up Speed This Month ACCESSWIRE
08:21AM  3 Brand-Name Marijuana Stocks Short-Sellers Are Liable to Target Motley Fool
Feb-07-19 03:22PM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending 31 December 2018 and Host Conference Call on 26 February 2019 GlobeNewswire
11:44AM  Zynerba Stock Is Marijuana-Adjacent Play Worth a Look InvestorPlace
Feb-06-19 11:20AM  Top Cannabis and Biotech Stocks To Watch ACCESSWIRE
08:21AM  The 13 Largest Pot Stocks by Market Cap Motley Fool
Feb-05-19 01:22PM  Pot Stocks are on a High: Play These Marijuana ETFs Zacks
10:30AM  Biotech on the Brink of Breaking Out ACCESSWIRE
Feb-04-19 03:26PM  420 Investor: GW Pharma Investors May Have To Wait Out Short-Term Volatility Benzinga
Feb-02-19 12:06PM  Sorry, Folks, but No Marijuana Super Bowl Ads This Year Motley Fool
Feb-01-19 01:02PM  Cannabis Company Surges After Winning the POT Ticker Lottery Yahoo Finance Video
10:55AM  5 Top Performing Stocks of Marijuana ETF Zacks
08:30AM  Biotechs to Put on Your Watchlist ACCESSWIRE
08:21AM  3 Top Marijuana Stocks to Avoid Like the Plague in February Motley Fool
Jan-31-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
04:09PM  Better Buy: GW Pharmaceuticals vs. Cara Therapeutics Motley Fool
Jan-30-19 08:00AM  Biotechs You Need to Radar Now ACCESSWIRE
Jan-29-19 12:58PM  How to Invest in Medical Marijuana Stocks Motley Fool
10:05AM  Can GW Pharmaceuticals (GWPH) Deliver a Beat in Q1 Earnings? Zacks
08:30AM  Wall Street's Favorite Cannabis Stock Benzinga
Jan-26-19 09:06AM  These 6 Marijuana Polls All Share 1 Thing in Common Motley Fool
Jan-24-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
Jan-23-19 11:45AM  4 Marijuana Stocks Setting The Standard On Wednesday (1/23/19) ACCESSWIRE
09:07AM  The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Innovative Industrial Properties, KushCo and Canopy Growth Zacks
Jan-22-19 02:05PM  4 Marijuana Stocks Getting A Boost From Today's Headlines ACCESSWIRE
08:35AM  4 Marijuana Stocks That Look Profitable in 2019 Zacks
Jan-21-19 09:56AM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gover Justin D.Chief Executive OfficerMar 15Option Exercise0.0047,85162564,960Mar 19 07:00 PM
Gover Justin D.Chief Executive OfficerMar 15Sale14.0123,400327,834541,541Mar 19 07:00 PM
MACKEY CATHERINE JDirectorMar 13Sale14.3988812,77819,284Mar 15 09:15 PM
GUY GEOFFREY W DRExecutive ChairmanMar 04Sale14.75900,00013,275,0008,141,521Mar 05 09:05 PM
Brown CabotDirectorMar 01Option Exercise3.5548,540172,21855,740Mar 05 09:09 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Option Exercise1.07576,000618,5099,041,521Mar 05 09:05 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.38576,0008,281,2358,465,521Mar 01 08:01 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.49300,0004,347,000103,925Mar 05 09:05 PM
Knappertz VolkerChief Medical OfficerMar 01Sale14.463,73253,9658,736Mar 05 09:06 PM
Brown CabotDirectorMar 01Sale14.3852,104749,0463,636Mar 05 09:09 PM
Gangolli Julian SPresident, North AmericaFeb 26Option Exercise0.0011,25615112,548Feb 28 05:09 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Option Exercise0.0010,4041415,768Feb 28 05:00 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Option Exercise0.009,612129,612Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 26Option Exercise0.0022,44029392,885Feb 28 05:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Option Exercise0.008,4361116,608Feb 28 05:05 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale12.4511,112138,328381,773Feb 28 05:02 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale12.434,64457,7034,968Feb 28 05:00 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale12.455,23265,12410,536Feb 28 05:00 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale12.464,14051,56812,468Feb 28 05:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Sale12.456,00074,696106,548Feb 28 05:09 PM
Gover Justin D.Chief Executive OfficerFeb 13Sale12.5022,620282,750370,445Feb 15 04:31 PM
Secor AliciaDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:23 PM
Brown CabotDirectorJan 03Option Exercise0.003,580523,808Mar 15 09:16 PM
MACKEY CATHERINE JDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:15 PM
Gover Justin D.Chief Executive OfficerJan 02Sale8.3322,620188,407393,065Jan 04 04:15 PM
Gover Justin D.Chief Executive OfficerDec 20Option Exercise0.0045,24059415,685Dec 26 04:15 PM
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM